132 related articles for article (PubMed ID: 15156159)
41. Identification of novel methylation markers in hepatocellular carcinoma using a methylation array.
Shin SH; Kim BH; Jang JJ; Suh KS; Kang GH
J Korean Med Sci; 2010 Aug; 25(8):1152-9. PubMed ID: 20676325
[TBL] [Abstract][Full Text] [Related]
42. Epigenetic identification of ubiquitin carboxyl-terminal hydrolase L1 as a functional tumor suppressor and biomarker for hepatocellular carcinoma and other digestive tumors.
Yu J; Tao Q; Cheung KF; Jin H; Poon FF; Wang X; Li H; Cheng YY; Röcken C; Ebert MP; Chan AT; Sung JJ
Hepatology; 2008 Aug; 48(2):508-18. PubMed ID: 18666234
[TBL] [Abstract][Full Text] [Related]
43. Increased expression of COX-2 in nontumor liver tissue is associated with shorter disease-free survival in patients with hepatocellular carcinoma.
Kondo M; Yamamoto H; Nagano H; Okami J; Ito Y; Shimizu J; Eguchi H; Miyamoto A; Dono K; Umeshita K; Matsuura N; Wakasa K; Nakamori S; Sakon M; Monden M
Clin Cancer Res; 1999 Dec; 5(12):4005-12. PubMed ID: 10632332
[TBL] [Abstract][Full Text] [Related]
44. MicroRNA-148a is silenced by hypermethylation and interacts with DNA methyltransferase 1 in hepatocellular carcinogenesis.
Long XR; He Y; Huang C; Li J
Int J Oncol; 2014 Jun; 44(6):1915-22. PubMed ID: 24714841
[TBL] [Abstract][Full Text] [Related]
45. Effect of promoter methylation of the p16 gene on phosphorylation of retinoblastoma gene product and growth of hepatocellular carcinoma cells.
Maeta Y; Shiota G; Okano J; Murawaki Y
Tumour Biol; 2005; 26(6):300-5. PubMed ID: 16254459
[TBL] [Abstract][Full Text] [Related]
46. Genetic and epigenetic inactivation of T-cadherin in human hepatocellular carcinoma cells.
Chan DW; Lee JM; Chan PC; Ng IO
Int J Cancer; 2008 Sep; 123(5):1043-52. PubMed ID: 18553387
[TBL] [Abstract][Full Text] [Related]
47. Epigenetic silencing of WIF-1 in hepatocellular carcinomas.
Deng Y; Yu B; Cheng Q; Jin J; You H; Ke R; Tang N; Shen Q; Shu H; Yao G; Zhang Z; Qin W
J Cancer Res Clin Oncol; 2010 Aug; 136(8):1161-7. PubMed ID: 20119713
[TBL] [Abstract][Full Text] [Related]
48. Silencing of PCDH10 in hepatocellular carcinoma via de novo DNA methylation independent of HBV infection or HBX expression.
Fang S; Huang SF; Cao J; Wen YA; Zhang LP; Ren GS
Clin Exp Med; 2013 May; 13(2):127-34. PubMed ID: 22543497
[TBL] [Abstract][Full Text] [Related]
49. OCIAD2 suppressed tumor growth and invasion via AKT pathway in Hepatocelluar carcinoma.
Wu D; Yang X; Peng H; Guo D; Zhao W; Zhao C; Zhou X
Carcinogenesis; 2017 Sep; 38(9):910-919. PubMed ID: 28911005
[TBL] [Abstract][Full Text] [Related]
50. Promoter histone H3 lysine 9 di-methylation is associated with DNA methylation and aberrant expression of p16 in gastric cancer cells.
Meng CF; Zhu XJ; Peng G; Dai DQ
Oncol Rep; 2009 Nov; 22(5):1221-7. PubMed ID: 19787243
[TBL] [Abstract][Full Text] [Related]
51. Tissue factor pathway inhibitor-2 as a frequently silenced tumor suppressor gene in hepatocellular carcinoma.
Wong CM; Ng YL; Lee JM; Wong CC; Cheung OF; Chan CY; Tung EK; Ching YP; Ng IO
Hepatology; 2007 May; 45(5):1129-38. PubMed ID: 17464989
[TBL] [Abstract][Full Text] [Related]
52. Predictive value of expression and promoter hypermethylation of XAF1 in hepatitis B virus-associated hepatocellular carcinoma treated with transplantation.
Zhang F; Wu LM; Zhou L; Chen QX; Xie HY; Feng XW; Zheng SS
Ann Surg Oncol; 2008 Dec; 15(12):3494-502. PubMed ID: 18830757
[TBL] [Abstract][Full Text] [Related]
53. Analysis of possible mechanisms accounting for raf-1 kinase inhibitor protein downregulation in hepatocellular carcinoma.
Poma P; Labbozzetta M; Vivona N; Porcasi R; D'Alessandro N; Notarbartolo M
OMICS; 2012 Nov; 16(11):579-88. PubMed ID: 23095110
[TBL] [Abstract][Full Text] [Related]
54. DNMT1 mediated promoter methylation of GNAO1 in hepatoma carcinoma cells.
Xu D; Du M; Zhang J; Xiong P; Li W; Zhang H; Xiong W; Liu F; Liu J
Gene; 2018 Jul; 665():67-73. PubMed ID: 29709639
[TBL] [Abstract][Full Text] [Related]
55. Inactivation of the DNA repair gene O6-methylguanine-DNA methyltransferase by promoter hypermethylation and its relationship to aflatoxin B1-DNA adducts and p53 mutation in hepatocellular carcinoma.
Zhang YJ; Chen Y; Ahsan H; Lunn RM; Lee PH; Chen CJ; Santella RM
Int J Cancer; 2003 Feb; 103(4):440-4. PubMed ID: 12478658
[TBL] [Abstract][Full Text] [Related]
56. Reduced expression of insulin-like growth factor binding protein-3 and its promoter hypermethylation in human hepatocellular carcinoma.
Hanafusa T; Yumoto Y; Nouso K; Nakatsukasa H; Onishi T; Fujikawa T; Taniyama M; Nakamura S; Uemura M; Takuma Y; Yumoto E; Higashi T; Tsuji T
Cancer Lett; 2002 Feb; 176(2):149-58. PubMed ID: 11804742
[TBL] [Abstract][Full Text] [Related]
57. Silencing of glutathione S-transferase P1 by promoter hypermethylation and its relationship to environmental chemical carcinogens in hepatocellular carcinoma.
Zhang YJ; Chen Y; Ahsan H; Lunn RM; Chen SY; Lee PH; Chen CJ; Santella RM
Cancer Lett; 2005 Apr; 221(2):135-43. PubMed ID: 15808399
[TBL] [Abstract][Full Text] [Related]
58. Hepatic cyclooxygenase-2 overexpression induced spontaneous hepatocellular carcinoma formation in mice.
Chen H; Cai W; Chu ESH; Tang J; Wong CC; Wong SH; Sun W; Liang Q; Fang J; Sun Z; Yu J
Oncogene; 2017 Aug; 36(31):4415-4426. PubMed ID: 28346420
[TBL] [Abstract][Full Text] [Related]
59. Specific COX-2 inhibitor, NS-398, suppresses cellular proliferation and induces apoptosis in human hepatocellular carcinoma cells.
Cheng AS; Chan HL; Leung WK; Wong N; Johnson PJ; Sung JJ
Int J Oncol; 2003 Jul; 23(1):113-9. PubMed ID: 12792783
[TBL] [Abstract][Full Text] [Related]
60. The silencing of RECK gene is associated with promoter hypermethylation and poor survival in hepatocellular carcinoma.
Zhang C; Ling Y; Zhang C; Xu Y; Gao L; Li R; Zhu J; Fan L; Wei L
Int J Biol Sci; 2012; 8(4):451-8. PubMed ID: 22419890
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
